Mitochondrial function, morphology and metabolic parameters improve after switching from stavudine to a tenofovir-containing regimen.

Gerschenson M, Kim C, Berzins B, Taiwo B, Libutti DE, Choi J, Chen D, Weinstein J, Shore J, da Silva B, Belsey E, McComsey GA, Murphy RL. Mitochondrial function, morphology and metabolic parameters improve after switching from stavudine to a tenofovir-containing regimen. J Antimicrob Chemother. 2009 Jun; 63(6):1244-50.

View in: PubMed

subject areas

Adenine
Adipose Tissue
Adult
Anti-HIV Agents
Body Fat Distribution
CD4 Lymphocyte Count
Deoxyguanosine
F2-Isoprostanes
Glutathione
HIV Infections
HIV-Associated Lipodystrophy Syndrome
Humans
Lamivudine
Male
Mitochondria
Pyrimidinones
Ritonavir
Stavudine
Treatment Outcome
Viral Load

authors with profiles

Mariana Gerschenson, PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support